GPBAR1 and gastric cancer: Having shown a potent pro-metastatic activity of GPBAR1 ligands in gastric cancer cells, as indicated by increased cells adhesion and migration activities, we have then investigated whether GPBAR1 activation induces phenotypic changes consistent with acquisition of a mesenchymal phenotype.